Andersson M - Search Results

1

Breast conserving treatment in Denmark, 1989-1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group.

Ewertz M, Kempel MM, Düring M, Jensen MB, Andersson M, Christiansen P, Kroman N, Rasmussen BB, Overgaard M. Ewertz M, et al. Among authors: andersson m. Acta Oncol. 2008;47(4):682-90. doi: 10.1080/02841860802032769. Acta Oncol. 2008. PMID: 18465336

2

Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001.

Andersson M, Jensen MB, Engholm G, Henrik Storm H. Andersson M, et al. Acta Oncol. 2008;47(4):755-64. doi: 10.1080/02841860801978921. Acta Oncol. 2008. PMID: 18465345 Clinical Trial.

3

Evaluation of and quality assurance in HER2 analysis in breast carcinomas from patients registered in Danish Breast Cancer Group (DBCG) in the period of 2002-2006. A nationwide study including correlation between HER-2 status and other prognostic variables.

Rasmussen BB, Andersson M, Christensen IJ, Møller S. Rasmussen BB, et al. Among authors: andersson m. Acta Oncol. 2008;47(4):784-8. doi: 10.1080/02841860801989779. Acta Oncol. 2008. PMID: 18465349

4

Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer.

Ejlertsen B, Mouridsen HT, Jensen MB, Andersen J, Andersson M, Kamby C, Knoop AS; Danish Breast Cancer Cooperative Group. Ejlertsen B, et al. Among authors: andersson m. Cancer. 2010 May 1;116(9):2081-9. doi: 10.1002/cncr.24969. Cancer. 2010. PMID: 20186830 Free article. Clinical Trial.

5

Supraclavicular recurrence after early breast cancer: a curable condition?

Pedersen AN, Møller S, Steffensen KD, Haahr V, Jensen M, Kempel MM, Jepsen SL, Madsen EL, Roslind A, Sandberg E, Schöllkopf C, Sørensen PG, Windfeldt KM, Andersson M. Pedersen AN, et al. Among authors: andersson m. Breast Cancer Res Treat. 2011 Feb;125(3):815-22. doi: 10.1007/s10549-010-0918-8. Epub 2010 May 8. Breast Cancer Res Treat. 2011. PMID: 20454924

6

Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1.

Edlund P, Ahlgren J, Bjerre K, Andersson M, Bergh J, Mouridsen H, Holmberg SB, Bengtsson NO, Jakobsen E, Møller S, Lindman H, Blomqvist C. Edlund P, et al. Among authors: andersson m. Acta Oncol. 2011 Apr;50(3):329-37. doi: 10.3109/0284186X.2011.554435. Epub 2011 Feb 8. Acta Oncol. 2011. PMID: 21299448 Clinical Trial.

7

One year of adjuvant tamoxifen compared with chemotherapy and tamoxifen in postmenopausal patients with stage II breast cancer.

Ejlertsen B, Jensen MB, Elversang J, Rasmussen BB, Andersson M, Andersen J, Nielsen DL, Cold S, Mouridsen HT. Ejlertsen B, et al. Among authors: andersson m. Eur J Cancer. 2013 Sep;49(14):2986-94. doi: 10.1016/j.ejca.2013.05.006. Epub 2013 Jun 8. Eur J Cancer. 2013. PMID: 23756360 Clinical Trial.

8

Risk of contralateral breast cancer after tamoxifen use among Danish women.

Mellemkjær L, Steding-Jessen M, Frederiksen K, Andersson M, Ejlertsen B, Jensen MB, Olsen JH. Mellemkjær L, et al. Among authors: andersson m. Ann Epidemiol. 2014 Nov;24(11):843-8. doi: 10.1016/j.annepidem.2014.08.003. Epub 2014 Sep 6. Ann Epidemiol. 2014. PMID: 25277504

9

Incidence of metachronous contralateral breast cancer in Denmark 1978-2009.

Rasmussen CB, Kjær SK, Ejlertsen B, Andersson M, Jensen MB, Christensen J, Langballe R, Mellemkjær L. Rasmussen CB, et al. Among authors: andersson m. Int J Epidemiol. 2014 Dec;43(6):1855-64. doi: 10.1093/ije/dyu202. Epub 2014 Oct 16. Int J Epidemiol. 2014. PMID: 25326461

10

Risk of skin cancer following tamoxifen treatment in more than 16,000 breast cancer patients: a cohort study.

Praestegaard C, Kjaer SK, Andersson M, Steding-Jensen M, Frederiksen K, Mellemkjaer L. Praestegaard C, et al. Among authors: andersson m. Breast Cancer. 2016 Nov;23(6):908-916. doi: 10.1007/s12282-015-0660-5. Epub 2015 Dec 11. Breast Cancer. 2016. PMID: 26660140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,907 results

Search Page

Filters